Abeona Therapeutics (ABEO) Other Accumulated Expenses (2021 - 2025)

Abeona Therapeutics' Other Accumulated Expenses history runs 5 years deep, the most recent figure standing at $2000.0 for Q4 2025.

• On a quarterly basis, Other Accumulated Expenses fell 96.88% year-over-year to $2000.0 in Q4 2025; TTM through Dec 2025 was $2000.0, a 96.88% decrease from a year earlier, with the FY2025 full-year figure at $2000.0, down 96.88% from the prior year.
• Other Accumulated Expenses eased to $2000.0 in Q4 2025 per ABEO's latest filing, from $35000.0 in the prior quarter.
• Across five years, Other Accumulated Expenses topped out at $317000.0 in Q1 2025 and bottomed at $1000.0 in Q4 2023.
• The 5-year median for Other Accumulated Expenses is $72000.0 (2024), against an average of $115071.4.
• Across the five-year window, Other Accumulated Expenses tumbled 99.51% in 2024 and jumped 31600.0% in 2025, its largest moves.
• Year by year, Other Accumulated Expenses stood at $296000.0 in 2021, then sank by 31.08% to $204000.0 in 2022, then sank by 99.51% to $1000.0 in 2023, then surged by 6300.0% to $64000.0 in 2024, then sank by 96.88% to $2000.0 in 2025.
• Per Business Quant, the three latest ABEO Other Accumulated Expenses figures stand at $2000.0 (Q4 2025), $35000.0 (Q3 2025), and $80000.0 (Q2 2025).